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Abstract: We searched the primary sequence of influenza A H5N1 polyprotein for hexamer 
amino acid sequences shared with human proteins using the Protein International Resource 
database and the exact peptide matching analysis program. We find that the viral polyprotein 
shares numerous hexapeptides with the human proteome. The human proteins involved in the 
viral overlap are represented by antigens associated with basic cell functions such as proliferation, 
development, and differentiation. Of special importance, many human proteins that share peptide 
sequences with influenza A polyprotein are antigens such as reelin, neurexin I-α, myosin-IXa, 
Bardet–Biedl syndrome 10 protein, Williams syndrome transcription   factor, disrupted in schizo-
phrenia 1 protein, amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein, 
fragile X mental retardation 2 protein, and jouberin. That is, the viral-vs-human overlap involves 
human proteins that, when altered, have been reported to be potentially associated with multiple 
neurological disorders that can include autism, epilepsy, obesity, dystonia, ataxia–telangiectasia, 
amyotrophic lateral sclerosis, sensorineural deafness, sudden infant death syndrome, Charcot-
Marie-Tooth disease, and myelination. The present data are discussed as a possible molecular 
basis for understanding influenza A viral escape from immunosurveillance and for defining 
anti-influenza immune-therapeutic approaches devoid of collateral adverse events.
Keywords: peptide sharing, neurological disorders, host-pathogen relationships, viral escape 
from immunosurveillance
Introduction
Many fundamental questions remain unanswered in virology. Virus-associated patholo-
gies and phenomena (such as tissue tropism, chronic infection, the viral role in cancer) 
are yet to be explained. Likewise, we remain ignorant of the basic mechanisms that 
  regulate viral quiescence and activation.1,2 Moreover, as a fundamental priority step 
in any   possible therapeutic approach, we need to solve the enigma of successful virus 
escape from immune surveillance.3,4
In order to understand the molecular basis of viral immunogenicity and pathogenesis, 
we analyze, quantitatively and qualitatively, the peptide-sharing platform between viruses 
and human proteins.5–7 We use short peptide motifs as scanning units because 5–6 amino 
acids define functional modules with a central role in cell biology and immunology.8 
Indeed, scientific reports indicate that 5–6 amino acids is a sufficient minimal determi-
nant in antigen–antibody recognition.8,9 Also, it is known that the optimal T-cell epitope 
length ranges between 9 and 15 amino acids, with the central 5–6 amino acid residues 
playing a major role in establishing specific immune interactions.10 Thus, according to 
our previous studies too,11 the structural features of an immunogenic T-cell epitope may Biologics: Targets & Therapy 2010:4 submit your manuscript | www.dovepress.com
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be located in a central immune unit formed by 5–6 residues 
flanked by MHC binding terminal residues.12–15
In the present study, we investigate the influenza A H5N1 
polyprotein-vs-human proteome overlap at the hexapeptide 
level. We report that viral matches occur in numerous human 
proteins associated with fundamental crucial functions. 
In particular, we describe the viral hexapeptide matches 
  occurring in proteins specifically expressed in the central 
nervous system (CNS).
Methods
The influenza A virus (A/Goose/Guangdong/1/96/H5N1, 
polyprotein length: 4,426 aa; 10 proteins) is described at the 
URL www.expasy.org/viralzone/all_by_species/130.html. 
Viral proteins, abbreviations, UniProtKB/Swiss-Prot acces-
sion numbers, and entry names are as follows: nonstructural 
protein 1 (NSP1, Q9Q0L6, NS1_I96A0); nuclear export 
  protein (NEP, Q9Q0L7, NEP_I96A0); matrix protein 1 (MP1, 
Q9Q0L8, M1_I96A0); matrix protein 2 (MP2, Q9Q0L9, 
M2_I96A0); hemagglutinin (HA, Q9Q0U6, HEMA_I96A0); 
neuraminidase (NA, Q9Q0U7, NRAM_I96A0); nucleo-
capsid protein (NC, Q9Q0U8, Q9Q0U8_I96A0); polymerase 
acidic protein (PA, Q9Q0U9, PA_I96A0); ribonucleic acid 
(RNA)-directed RNA polymerase catalytic subunit (RDRP, 
Q9Q0V0, RDRP_I96A0); and polymerase basic subunit 2 
(PB2, Q9Q0V1, PB2_I96A0).
The influenza A polyprotein primary sequence was 
dissected into hexapeptides that were analyzed for exact 
matching with the human proteome using the Protein Infor-
mation Resource perfect match program (pir.georgetown.edu/
pirwww/search/peptide.shtml).16 The hexapeptide sequences 
were offset by one residue, ie, overlapping by 5 residues, 
MDSNTI, DSNTIT, SNTITS, NTITSF, etc. The human 
proteome consisted of 36,103 proteins and 8,247,275 unique 
hexamers at the time of analysis. Human protein sequences 
corresponding to fragments, duplicates, and obsolete entries 
were not considered. Functions of human proteins and poten-
tial disease associations were derived from the Universal 
Protein Resource (uniprot.org/uniprot). As a control, the pri-
mary sequence of tobacco mosaic virus (TMV) coat protein 
(UniProtKB/Swiss-Prot P69687, COAT_TMV) was used.
Results
Quantitative analysis of the hexapeptide 
overlapping between influenza  
A polyprotein and human proteomes
Figure 1 describes the influenza A overlapping pattern to the 
human proteome at the hexapeptide level (ie, the number of 
occurrences in the human proteome for each viral hexapep-
tide). It can be seen that all the 10 influenza proteins, regard-
less of their functions or lengths, present perfect hexapeptide 
matches to human proteins. Moreover, Figure 1 shows that 
the overlapping pattern has a similar behavior in the 10 influ-
enza A proteins, with viral peptide areas scarcely represented 
in the human proteins alternating with viral peptide areas 
highly repeated in human proteins.
Numerically, the viral-vs-human overlap is defined by 
1,905 perfect matches (Table 1). Theoretically, the number 
of times a given viral hexamer might occur at random in 
the human proteome (calculated on the basis of the unique 
hexamers in viral and human proteomes) is 569.7. Therefore, 
the overlapping extent reported in Table 1 is about 3.3-fold 
higher than the theoretical value.
Qualitative analysis of the hexapeptide 
overlap of   influenza A polyprotein vs 
human proteins
The number of viral hexapeptide matches found in human 
proteins is high, and only a short survey is reported in Table 2, 
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Figure 1 Identity platform shared by influenza A polyprotein and the human proteome at the hexapeptide level. A) Location of the 10 viral proteins along the primary sequence 
of the influenza A polyprotein. Viral protein abbreviations as detailed in Methods section. B) Similarity profile of influenza A H5N1 polyprotein vs the human proteome at the 
hexapeptide level. The columns indicate the number of viral hexapeptide occurrences in the human proteome. hexapeptide amino acid sequences in one-letter code.Biologics: Targets & Therapy 2010:4 submit your manuscript | www.dovepress.com
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describing 74 viral hexapeptides occurring in 82 human   proteins. 
However, Table 2 clearly shows that the human proteins 
involved in the viral hexapeptide overlap exert key cellular func-
tions, and many of them have a specific localization in the brain. 
The functional relevance of the human proteins sharing viral 
hexapeptides is illustrated in the following examples: Alstrom 
syndrome protein 1 (ALMS1), involved in sensory transduc-
tion and expressed in fetal brain; Laforin-interacting protein, 
associated with progressive myoclonic epilepsy type 2; chloride 
channel protein 2 (CLCN2), defects in which may be the cause 
of epilepsy or generalized tonic–clonic seizures in childhood 
or adolescence; Niemann–Pick C1-like protein 1 (NPCL1), 
alterations of which may be associated with   Niemann–Pick 
C disease and characterized by cognitive impairment and 
ataxia; Huntingtin protein and   Huntingtin-interacting protein 
3; the paroxysmal nonkinesiogenic dyskinesia (PNKD) protein, 
defects of which are the cause of dystonia type 8; gemin-4, a 
component of the complex survival of motor neuron (SMN) that 
is associated with the neurodegenerative disease spinal muscular 
atrophy; and dehydrogenase enzymes, such as the mitochondrial 
glutamate dehydrogenase 1 (involved in learning and memory 
and, when altered, causes   hyperinsulinism–hyperammonemia 
syndrome) and glutamate dehydrogenase 2 (involved in 
neurotransmission).
Interestingly, viral hexapeptides are found in human 
proteins that have been specifically associated with sudden 
death, including sudden infant death syndrome, ie, trifunc-
tional enzyme subunit β (ECHB), ryanodine receptor (RYR) 
2 or cardiac muscle-type ryanodine receptor, caveolin-3 
(CAV3), and ankyrin-2 (ANK2) or brain ankyrin (Table 2). 
Of special note, titin, that has been linked to cardiac failure 
and sudden cardiac death,17 presents 14 exact matches in 
common with influenza A H5N1 polyprotein (ie, the  matches 
along the viral polyprotein are, in the order: LKANFS, 
SDSSDP, SYIVEK, PKSSWS, AELLVL, DPKKTG, PKK-
TGG, SGAAGA, GAAGAA, SAAFED, LSIEDP, ELQDIE, 
TNDAGS, KEEEVL).
On the whole, a result emerging from the analysis given in 
Table 2 is that the viral-vs-human overlap is physiologically 
complex with respect to the human proteins involved. As 
a paradigmatic snapshot, the viral PA protein shares the 
GVEEGS sequence (aa 627–632) with the human Msx2-
interacting protein (hMINT or SMART/histone deacetylase 
[HDAC1]-associated repressor protein). Human MINT is an 
essential corepressor protein, which probably   regulates dif-
ferent key pathways, such as the Notch pathway. The   protein 
is expressed at high levels in brain, testis, spleen, and thymus 
and is induced by the 17β-estradiol hormone. The (inter)
actions exerted by hMINT are physiologically important. 
Indeed, Notch dysregulation may underlie some of the dis-
tinctive clinical and pathologic features of tuberous sclerosis 
complex, a multisystem tumor suppressor gene syndrome 
characterized by neurologic disorders (seizures, mental 
retardation, autism); pulmonary lymphangioleyomyomato-
sis; and hamartomatous tumors of the brain, heart, kidney, 
and skin.18,19
Quantitatively, in a few instances, the viral-vs-human over-
lapping involves multiple occurrences of the same hexapeptide. 
Table 2 shows that the viral DSNTIT hexapeptide present in 
the human ALMS1 is present in the influenza A NSP1 and 
NEP. Likewise, multiple occurrences of a viral hexapeptide 
may occur in the same human protein. For example, the 
  influenza A RDRP510–515PSFGVS hexapeptide occurs 17 
times in the human AHNAK2 protein, while the influenza A 
PA 118–123IEIGVT peptide occurs 3 times in human neuralized-
like   protein 4. Also, tubulin and sodium channel protein type 
10 have a   heptapeptide in common with the influenza A poly-
protein, while human ataxia–telangiectasia mutated protein 
(ATM) has 2 different viral hexapeptides (corresponding to 
NC375–380 DSSTLE and PA626–631KGVEEG sequences). Similar 
quantitative and   qualitative data were obtained by analyzing 
the primary sequence of proteins from influenza A H1N1 
virus, strain Alabama/02/2009, National Center for Biotech-
nology Information (NCBI)   Taxonomy ID: 645728 (data not 
shown).
Analysis of the hexapeptide overlap  
of influenza A vs human proteins 
associated with behavioral syndromes 
and crucial function(s) in the brain  
and/or in the peripheral nervous system
An analysis of Table 2 shows that a number of proteins con-
taining viral hexapeptides are specifically located in selected 
brain areas, such as the amygdala, substantia nigra, caudate 
nucleus, thalamus and hypothalamus, hippocampus, and 
cerebellum (mentioned in boldface in Table 2). Following 
Table  1  numerical  description  of  the  hexapeptide  overlap 
between influenza A polyprotein and Homo sapiens proteome
Unique viral hexamers 4,416
Viral hexamers occurring in the human proteins  
(including multiple occurrences)a
1,905
expected number of viral hexamer occurrences  
in the human proteome
569
ahuman protein sequences corresponding to fragments, duplicates, and obsolete 
entries were filtered out.Biologics: Targets & Therapy 2010:4 submit your manuscript | www.dovepress.com
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Table 2 Examples of human proteins sharing hexapeptide sequence(s) with influenza A H5N1 polyprotein
Influenza A hexapeptide Human protein descriptiona
Protein Aa pos Sequence
nsP1 2 DsnTiTb ALMS1: Alstrom syndrome protein 1. involved in sensory transduction of extracellular signals, such as light, 
taste, sound, touch, or smell, into electric signals. expressed in the pancreas β-cells of the islets in fetal aorta and 
the brain. Defects in ALMS1 are the cause of Alstrom syndrome, characterized by cone-rod retinal dystrophy, 
neurosensory hearing loss, early childhood obesity, and type 2 diabetes mellitus.
42 ALKgrg EPMIP: EPM2A interacting protein 1. Laforin-interacting protein. The first recognized Laforin binding partner that 
may play a critical role in discovering the underlying pathogenesis of progressive myoclonic epilepsy type 2 (Lafora 
disease), characterized by grand mal seizures and/or myoclonus at about 15 years of age. Mental deterioration 
follows, often with psychotic features. 
Q96A48: Paroxysmal nonkinesiogenic dyskinesia (PNKD) protein. Myofibrillogenesis regulator 1. PNKD plays 
a role in the development of cardiac hypertrophy. Isoform 1 is only expressed in the brain. isoform 2 is 
ubiquitous. Defects in PnKD cause dystonia type 8, a paroxysmal nonkinesigenic dystonia/dyskinesia.
47 gsTLgL GRIP2: glutamate receptor-interacting protein 2. glutamate receptors mediate neurotransmission in the brain  
and play an important role in neural plasticity, neural development, and neurodegeneration. griP1 and griP2 are  
widely expressed in brain, with the highest levels in the cerebral cortex, hippocampus, and olfactory  
bulb. GRIP1 is expressed in early development, specifically postnatal days 8–10, while GRIP2 is expressed during 
later developmental stages.
50 LgLDLr DHE3: glutamate dehydrogenase 1, mitochondrial. involved in learning and memory. Defects in Dhe3 are the 
cause of hyperinsulinism–hyperammonemia syndrome. 
DHE4: glutamate dehydrogenase 2, mitochondrial. important for recycling the chief excitatory neurotransmitter, 
glutamate, in neurotransmission. expressed in retina, testis, and brain. 
NPCL1: niemann–Pick c1-like protein 1. Plays a major role in cholesterol homeostasis. niemann–Pick c disease 
is characterized by a disruption of sphingolipid and cholesterol trafficking that produces cognitive impairment, 
ataxia, and death, often in childhood.
77 LKiAiA P04114: Apolipoprotein B (APOB)-100. The APOB is a major protein constituent of chylomicrons. Defects 
in APOB are a cause of familial hypobetalipoproteinemia. subjects have low plasma low-density lipoprotein 
(LDL) cholesterol and APOB-100 concentrations. clinical presentation varies from no symptoms to severe 
gastrointestinal and neurological dysfunction similar to abetalipoproteinemia.
82 AssPAP CTRO: Citron. Rho-interacting, serine/threonine-protein kinase 21. Required for KIF14 localization to the central 
spindle and midbody. regulates the development of the cns. 
NCOR1: nuclear receptor corepressor 1. Mediates transcription repression of thyroid hormone and retinoic acid 
receptors. The corresponding gene is located between the cMT and smith–Magenis syndrome critical regions on 
chromosome 17. Forms a large corepressor complex that contains sin3A/B and histone deacetylases hDAc1 and 
hDAc2.
83 ssPAPr ITPR1: inositol 1,4,5-trisphosphate receptor (iP3r) type 1. The iP3r mediates calcium release following 
stimulation by inositol 1,4,5-trisphosphate. interacts with rYr1, rYr2, iTPr1, shAnK1, and shAnK3. Defects 
in iTPr1 are the cause of spinocerebellum ataxia type 15, with incoordination of gait, poor coordination of hands, 
speech, and eye movements, due to cerebellar degeneration.
107 PrQKiT PMM2: Phosphomannomutase 2. involved in the synthesis of gDP-mannose and dolichol-phosphate-mannose. 
Defects in PMM2 are the cause of Jaeken syndrome, characterized by severe encephalopathy with axial hypotonia, 
abnormal eye movement, psychomotor retardation, peripheral neuropathy, cerebellar hypoplasia, and retinitis 
pigmentosa.
141 LETLVS MLL3: Myeloid/lymphoid or mixed-lineage leukemia protein 3. histone-lysine n-methyltransferase MLL3. Methylates 
‘Lys-4’ of histone H3. H3 ‘Lys-4’ methylation represents a specific tag for epigenetic transcriptional activation. 
highly expressed in testis and ovary, followed by brain and liver. Within brain, expression is highest in the 
hippocampus, caudate nucleus, and substantia nigra.
178 igiLig IRAK3: interleukin-1 receptor-associated kinase 3. expressed in peripheral blood lymphocytes. Defects in irAK3 
are associated with susceptibility to asthma-related traits type 5, which include clinical symptoms such as coughing, 
wheezing, dyspnea, serum IgE levels, atopy, and atopic dermatitis.
205 ihDeng Q9HC59: The α-synuclein-interacting protein (sncAiP). synphilin-1c protein. Widely expressed, with highest 
levels in the brain, heart, and placenta. Defects in SNCAIP are a cause of Parkinson disease, characterized 
by bradykinesia, resting tremor, muscular rigidity, loss of dopaminergic neurons in the substantia nigra, and 
intraneuronal accumulations of aggregated proteins (ie, Lewy bodies) in surviving neurons.
neP 18 KMQLes GLRB: glycine receptor subunit β. A neurotransmitter-gated ion channel. Binding of glycine to its receptor 
produces hyperpolarization (inhibition of neuronal firing). Defects in GLRB are a cause of startle disease 
characterized by muscular rigidity of CNS origin, particularly in the neonatal period, and by an exaggerated startle 
response to unexpected acoustic or tactile stimuli.
(Continued)Biologics: Targets & Therapy 2010:4 submit your manuscript | www.dovepress.com
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Table 2 (Continued)
Influenza A hexapeptide Human protein descriptiona
Protein Aa pos Sequence
22 ESSSVD AHI1: Abelson helper integration site 1 protein homolog. Jouberin. highly expressed in primitive normal 
hematopoietic cells. expressed in the brain, particularly in neurons that give rise to the crossing axons 
of the corticospinal tract and superior cerebellum peduncles. Upregulated in leukemic cells at all stages 
of differentiation from patients with chronic myeloid leukemia. Defects in Ahi1 are the cause of Joubert syndrome 
type 3. Joubert syndrome is characterized by cerebellum ataxia, oculomotor apraxia, hypotonia, neonatal breathing 
abnormalities, and psychomotor delay. Neuroradiologically, it is characterized by cerebellum vermian hypoplasia/
aplasia, thickened and reoriented superior cerebellum peduncles, and abnormally large interpeduncular fossa (molar 
tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 3 shows 
minimal extra cns involvement and appears not to be associated with renal dysfunction.
24 SSVDLN VLDLR: Very low density lipoprotein (VLDL) receptor. Binds VLDL and transports it to cells by endocytosis. 
Binding to reelin induces tyrosine phosphorylation of Dab1. Deletions involving VLDLR may be the cause of 
cerebellum hypoplasia, with mental retardation, delayed ambulation, predominantly truncal ataxia, strabismus and 
pesplanus, seizures (in 40% of patients), and short stature (in 15% of patients).
36 erLKiY NARG1: nMDA receptor-regulated protein 1. important for vascular and neuronal development. controls 
retinal neovascularization. Found in brain (corpus callosum).
101 QALQLL SYT9: synaptotagmin-9. integral membrane protein involved in norepinephrine secretion.
104 QLLLEV ABCA1: Adenosine 5’-triphosphate (ATP)-binding cassette subfamily A member 1. Widely expressed. Defects in 
ABCA1 cause Tangier disease, a high density lipoprotein deficiency characterized by premature coronary artery 
disease, hepatosplenomegaly, recurrent peripheral neuropathy, and progressive muscle wasting and weakness. 
MESD1: Mesoderm development candidate 1.
MP1 15 VPSGPL SALL1: Sal-like protein 1. Zinc finger protein SALL1. Involved in organogenesis. Interacts with HDAC1, HDAC2, 
rBBP4, rBPP7, MTA1, and MTA2. highest levels expressed in the kidney. Lower levels in adult brain (enriched 
in corpus callosum, lower expression in substantia nigra) and liver. In fetal brain, expressed 
exclusively in neurons of the subependymal region of hypothalamus lateral to the third ventricle.
16 PsgPLK MYLK: Myosin light chain kinase (MLcK). smooth muscle. Telokin. implicated in smooth muscle contraction. 
implicated in the regulation of endothelial as well as vascular permeability. in the nervous system, it has been 
shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release 
at synapses formed between cultured sympathetic ganglion cells.
20 LKAeiA CNGA3: cyclic nucleotide-gated cation channel α-3. essential for the generation of light-evoked electrical 
responses in the red-, green- and blue-sensitive cones. Prominently expressed in retina. Defects in cngA3 are 
the cause of achromatopsia type 2 (or total color blindness or rod monochromacy).
38 DLeALM USH1G: Usher syndrome type-1g protein. required for normal hearing. expressed in vestibule of the inner 
ear, eye, and small intestine. Defects in USH1G are the cause of Usher syndrome type 1G, characterized by 
the association of retinitis pigmentosa and sensorineural deafness. Usher syndrome type 1 is characterized by 
prepubertal onset of progressive retinitis pigmentosa leading to blindness. 
Q86U74: Phosphoglucomutase-1. This enzyme participates in both the breakdown and synthesis of glucose.
54 PLTKgi Q6RJU1: rho gTPase-activating protein 20. expressed predominantly in the brain.
72 rgLQrr LAP4: Protein scribble homolog. scribble. involved in different aspects of epithelial and neuronal 
morphogenesis. Localizes to neuronal post- and presynaptic regions.
MP2 59 LKrgPs CLCN2: chloride channel protein 2. Functions include the regulation of cell volume. Defects in cLcn2 may 
be the cause of (1) epilepsy with grand mal seizures on awakening; (2) childhood absence epilepsy type 3, with 
onset at age 6–7 y, frequent absence seizures, and bilateral, synchronous, and symmetric 3-Hz spike waves on 
electroencephalogram (EEG); and (3) juvenile absence epilepsy characterized by tonic–clonic seizures on awakening.
hA 143 ASSGVS DOCK3: Dedicator of cytokinesis protein 3. Presenilin-binding protein. May be involved in Alzheimer disease. 
In normal brains, it is localized in the neuropil, while in brains affected by Alzheimer disease it is associated with 
neurofibrillary tangles. A chromosomal aberration involving DOCK3 may be a cause of early onset of behavioral/
developmental disorder with features of attention deficit–hyperactivity disorder. 
HD: huntingtin. huntington disease protein.
157 ssFFrn TBEc: Tubulin, epsilon 1.
158 SFFRNV TBEc: Tubulin, epsilon 1. see previous .
330 ATgLrn UBP3: Ubiquitin carboxyl-terminal hydrolase 3. Ubiquitous, with strongest expression in pancreas.
419 Lerrie DESM: Desmin. Intermediate filament found in muscle cells. Defects in desmin cause (1) desmin-related 
cardioskeletal myopathy, with skeletal muscle weakness, cardiac conduction blocks, arrhythmias, and restrictive 
heart failure; (2) cardiomyopathy dilated type 1i, resulting in congestive heart failure and arrhythmia, with risk of 
premature death; (3) neurogenic scapuloperoneal syndrome Kaeser type.
534 SIYSTV TMEM1: Trafficking protein particle complex subunit 10. Epilepsy holoprosencephaly candidate 1.
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Table 2 (Continued)
Influenza A hexapeptide Human protein descriptiona
Protein Aa pos Sequence
nA 17 VGIISL RYR1: ryanodine receptor 1. Present in skeletal muscle, cerebellum, and hippocampus. Defects in rYr1 are  
the cause of (1) malignant hyperthermia susceptibility type 1, one of the main causes of death due to anesthesia,  
with accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia, and even death; (2) central  
core disease, one of the conditions that produces the “floppy” infant, with neonatal hypotonia, delayed motor  
development, muscle weakness, and amyotrophy.
23 MLQign SC10Ac: sodium channel protein type 10, subunit α. Expressed in the dorsal root ganglia and sciatic 
nerve. Plays a role in neuropathic pain mechanisms.
24 LQigni SC10Ac: sodium channel protein type 10 subunit α. see previous entry.
28 niisiW TOP2B: Deoxyribonucleic acid (DnA) topoisomerase ii, β. Reduced activity of this enzyme may also play a role 
in ataxia–telangiectasia, a neurodegenerative disease that causes poor coordination and dilation of small blood 
vessels.
78 KAVASAV GEMI4: component of gems 4. gemin-4. P97. component of the sMn protein complex. sMn is the product of 
the neurodegenerative disease spinal muscular atrophy gene.
102 KDngir ECHB: Trifunctional enzyme subunit β, mitochondrial. hADhB. Defects in hADhB are a cause of trifunctional 
protein deficiency. Manifestations include hypoglycemia, cardiomyopathy, and sudden death.
440 gssisF CSMD2: cUB and sushi domain-containing protein 2. expressed at intermediate levels in the brain, including 
cerebellum, substantia nigra, hippocampus, and fetal brain.
463 LPFTiD TAAR5: Trace amine-associated receptor 5. Mediates aspects of movement control. expressed exclusively in 
skeletal muscle and selected areas of the brain (amygdala, hippocampus, caudate nucleus, hypothalamus, 
and thalamus).
nc 63 IERMVL HS70L: Heat shock 70 kDa protein (Hsp70) 1-Hom. Hsp70s stabilize proteins against aggregation.
127 eDATAg DPYS: Dihydropyrimidinase (DHP) protein. Defects in DPYS are the cause of DHP deficiency. DHP deficiency 
is characterized by dihydropyrimidinuria and associated with a variable clinical phenotype: epileptic or convulsive 
attacks, dysmorphic features, developmental delay, and congenital microvillous atrophy.
375 DssTLe ATMd: Ataxia–telangiectasia mutated protein. Defects in ATM cause ataxia–telangiectasia, characterized by 
cerebellum ataxia, blood vessel dilation in the conjunctiva, growth retardation, and sexual immaturity.
453 PEDVSF TBCD: Tubulin-specific chaperone D. Tubulin-folding protein. Involved in the first step of the tubulin-folding 
pathway. Modulates microtubule dynamics by capturing guanosine triphosphate (gTP)-bound β-tubulin.
PA 13 IVELAE RYR2: ryanodine receptor 2. rYr-2. cardiac muscle-type ryanodine receptor. expressed in heart muscle, brain 
(cerebellum and hippocampus), and placenta. expressed in myometrium during pregnancy. Defects in rYr2 
cause (1) arrhythmogenic right ventricular cardiomyopathy 2 and (2) catecholaminergic polymorphic ventricular 
tachycardia type that may degenerate into cardiac arrest and cause sudden death. 
ZDH17: Zinc finger palmitoyltransferase specific for a subset of neuronal proteins. Huntingtin-interacting 
protein 3. Highest expression in the brain cortex, cerebellum, occipital lobe, and caudate.
118 IEIGVT Q9H0B0e: Neuralized-like protein 4. Widely expressed at high levels (including brain).
343 AeLQDi Q4VY19: Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, β polypeptide.
351 eeKiPK Q2NKJ7: Neuronal-specific septin-3. Filament-forming cytoskeletal GTPase. GTPase activity is required for brain-
specific filament formation. Up-regulated during neuronal differentiation.
378 KVDFED CABP2: Caveolin-3. CAV3. Involved in repair mechanism of both skeletal muscle and cardiomyocytes. Defects 
in CAV3 cause (1) limb-girdle muscular dystrophy type 1C; (2) hyperCKmia (ie, elevated levels of serum creatine 
kinase); (3) rippling muscle disease; (4) cardiomyopathy familial hypertrophy, with dyspnea, syncope, collapse, 
palpitations, and chest pain; and (5) long QT syndrome type 9 (long QT syndromes cause syncope and sudden 
death in response to stress; they can present with a sentinel event of sudden cardiac death in infancy); (6) sudden 
infant death syndrome (siDs), the sudden death of an infant younger than 1yr that remains unexplained after a 
thorough case investigation, including a complete autopsy, examination of the death scene, and review of clinical 
history.
626 KGVEEG ATMd: serine-protein kinase ATM. Ataxia–telangiectasia mutated. see earlier entry.
627 GVEEGS MINT: Msx2-interacting protein. sMArT/hDAc1-associated repressor protein. regulates different key pathways 
such as the notch pathway. Expressed at high level in brain, testis, spleen, and thymus.
671 ALrDnL NBEAL: nBeA L1 protein. Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein. 
neurobeachin-like protein 1. Highly expressed in brain, kidney, prostate, and testis.
684 ggLYeA DOCK6: Dedicator of cytokinesis protein 6 guanine nucleotide exchange factor. Widely expressed. expressed at 
low level in spleen, cerebellum, hippocampus, and substantia nigra.
rDrP 202 QrTigK AFF2: Fragile X mental retardation 2 protein. expressed in hippocampus and amygdala.
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276 neKKAK DCX: neuronal migration protein doublecortin. Lissencephalin-X. involved in cortex lamination during cerebral cortex 
development. Highly expressed in neuronal cells of fetal brain (in the majority of cells of the cortical plate, 
intermediate zone, and ventricular zone). not expressed in other fetal tissues. in adults, highly expressed in the 
brain frontal lobe. Defects in DCX cause lissencephaly X-linked type 1, with mental retardation and seizures that are 
more severe in male patients. Affected boys show a thick cortex with absent or reduced gyri, feeding problems, abnormal 
muscular tone, seizures, and psychomotor retardation. Females display a less severe phenotype (“doublecortex”).
401 AsLsPg CAD22: cadherin-22. Pituitary and brain cadherin. 
SALL3: sal-like protein 3. Expressed in fetal brain of the 24th gestational week (in hippocampus, 
cortex, mediodorsal and ventrolateral thalamic nuclei, putamen, cerebellum, and brainstem).
510 PSFGVS Q8IVF2f: Protein AhnAK2. is a component of the dysferlin protein complex. in dysferlinopathies, reduction or 
absence of dysferlin correlates with a secondary muscle-specific loss of AHNAK.
616 MDeDYQ VP13A: Vacuolar protein sorting-associated protein 13A. Chorein. Higher expression is found in brain, 
heart, skeletal muscle, and kidney. Defects in VPS13A are the cause of chorea-acanthocytosis, characterized by 
hyperkinetic movements, abnormal erythrocyte morphology, psychiatric features, epilepsy, peripheral neuropathy, 
myopathy, oral self-mutilation, and basal ganglia atrophy in the brain.
702 sssYrr VIME: Vimentin. Vimentins are class-III intermediate filaments found especially in mesenchymal cells.
PB2 4 iKeLrD A0MZ66: Shootin-1. Localized in axons. Acts upstream of phosphoinositide 3-kinase (Pi3K). involved in the 
generation of internal asymmetric signals required for neuronal polarization.
128 GTEGPV HEXA: β-hexosaminidase subunit α. Defects in heXA are the cause of gM2-gangliosidosis type 1 also known as 
“Tay–Sachs disease,” with accumulation of GM2 gangliosides in the neuronal cells.
156 AKeAQD EZRI: Ezrin. Expressed in cerebral cortex, basal ganglia, hippocampus, hypophysis, and optic nerve. 
Stronger expression in gray matter of frontal lobe compared to white matter. Preferentially 
expressed in astrocytes of hippocampus, frontal cortex, thalamus, parahippocampal cortex, 
amygdala, insula, and corpus callosum. Very strong staining of the Purkinje cell layer and in part of 
the molecular layer of the infant brain compared to adult brain.
187 KeKKee RS14: 40s ribosomal protein s14. 
SFR11: Splicing factor, Arg/Ser-rich 11 that localizes with spliceosome components.
207 LERELV SPTN5: spectrin β chain, brain 4. spectrin, nonerythroid β chain 4. Detected prominently in the outer segments 
of photoreceptor rods and cones, and in the basolateral membrane and gastric epithelial cells. expressed in 
cerebellum, spinal cord, pituitary gland, stomach, liver, pancreas, kidney, bladder, and heart.
227 VYIEVL PCDBD: Protocadherin β-13. involved in the establishment of neuronal connections in the brain. 
Q5VY39: Protocadherin-15. essential for normal retinal and cochlear function. Found in the inner and outer 
synaptic layers, and the nerve fiber layer in adult and fetal retinas. Found in the supporting cells, outer sulcus 
cells, and spiral ganglion of fetal cochlea. Defects in PCDH15 cause (1) Usher syndrome type 1F, characterized 
by the association of retinitis pigmentosa and sensorineural deafness, (2) Usher syndrome type 1D/F, and (3) 
nonsyndromic sensorineural deafness autosomal recessive type 23.
274 ADPLAs TECT2: Tectonic-2. Participates in hedgehog-mediated patterning of the neural tube. During neural tube 
development, mouse tectonic is required for formation of most of the ventral cell types.
275 DPLAsL CNTP5: contactin-associated protein-like 5. caspr5. cnTnAP5. May play a role in the correct development 
and proper functioning of the peripheral and cns and may be involved in cell adhesion and intercellular 
communication. Belongs to the neurexin family.
277 LAsLLe FA38A: Protein FAM38A. in normal brain, expressed exclusively in neurons, not in astrocytes. In Alzheimer 
disease, expressed in approximately half of the activated astrocytes located around classical senile plaques.
316 gLriss MASS1: g-protein coupled receptor 98. gPr98. involved in the development of the cns. Defects in gPr98 
may be a cause of (1) Usher syndrome type 2C, characterized by the association of retinitis pigmentosa with 
sensorineural deafness; and (2) familial febrile convulsions type 4. Febrile convulsions are seizures in childhood 
without any evidence of intracranial infection or defined pathologic or traumatic cause.  Affects 2%–5% of children 
aged 3 m to 5 yr.
317 Lrisss LEPR: Leptin receptor. receptor for obesity factor (leptin). involved in the regulation of fat metabolism.
339 KKEEEV Q52LR0: Cingulin-like protein 1. Paracingulin. Localizes to the apical junction complex composed of tight 
and adherens junctions. Present in smooth muscle, spleen, testis, fetal brain, amygdala, corpus callosum, 
cerebellum, thalamus, and the subthalamic nucleus of adult brain. A chromosomal aberration involving 
CGNL1 is a cause of aromatase excess syndrome, characterized by estrogen excess.
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341 EEEVLT TTBK2: Tau-tubulin kinase 2. serine/threonine kinase, which is able to phosphorylate tau on serines. Defects in TTBK2 
cause spinocerebellum ataxia type 11. Patients show incoordination of gait and often poor coordination of hands, speech, 
and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord.
347 gnLQTL NEB2: neurabin-2. Modulates synaptic transmission and dendritic spine morphology. involved in g-protein 
coupled receptor signaling, including dopamine D2 receptors and α-adrenergic receptors.
476 RGVRVS ANK2: Ankyrin-2. Brain ankyrin. required for the regulation of neonatal cardiomyocyte contraction rate. 
Expressed in fetal brain and the temporal cortex of adult brain. Defects in AnK2 cause long QT 
syndrome type 4. Long QT syndromes cause syncope and sudden death in response to stress.
565 sQDPTM PSD5: 26s proteasome non-ATPase regulatory subunit 5. 26s proteasome subunit s5B.
678 DPDegT CELR2: cadherin egF LAg g-type receptor. Flamingo 1. receptor that may have an important role in cell–cell 
signaling during nervous system formation. highest expression in brain and testis. 
PCD19: Protocadherin-19. expressed in developing cortical plate, amygdala, and subcortical regions 
and in the ganglionic eminence. Defects in PcDh19 cause epilepsy (female-restricted), with mental 
retardation, and convulsive disorder, characterized by seizure onset in infancy and cognitive impairment. 
PCDGM: Protocadherin γ-c5. involved in the establishment of neuronal connections in the brain.
aUniProt/Swissprot accession numbers are given in bold. Brain and/or peripheral nervous system localization are given in boldface. For references and potential disease 
involvement, refer to www.uniprot.org; bDsnTiT is present in the viral neP too; cTubulin and sodium channel protein type 10, subunit α, have 2 consecutive overlapping viral 
hexapeptides; dThe ATM has 2 viral hexapeptides: NC375–380DSSTLE and PA626–631KGVEEG; eThe viral hexapeptide IEIGVT occurs 3 times in the human neuralized-like 
protein 4; fThe viral PSFGVS hexapeptide occurs 17 times in the human AHNAK2 protein.
this observation, we restricted our analysis by searching for 
viral-vs-human overlaps in proteins potentially relevant at the 
neurological level, focusing in particular on antigens linked to 
behavior and/or fundamental neurophysiological functions, 
such as myelin. The data obtained are illustrated in Tables 3 
and 4. Specifically, Table 3 reports that influenza A H5N1 poly-
protein shares viral hexapeptide sequences with many human 
proteins that have been associated with schizophrenia, autism, 
and similar   behavioral disorders, such as the   Williams–Beuren 
and   Bardet–Biedl syndromes.20–44 Some among the many 
human proteins that have influenza A motifs include neurexins, 
disrupted in schizophrenia 1 protein, and reelin (ie, antigens 
whose link with autistic syndromes is well documented, 
both scientifically and clinically).22,28,35,36 In a few cases, mul-
tiple viral hexapeptides occur in the same human protein: eg, 
human neurexin I-α protein contains 2 viral hexapeptides 
(NEP25–30SVDLNG and NC390–395TRSGGN peptides). Likewise, 
the human   Bardet–Biedl syndrome 10 protein contains the viral 
HA64–69KPLILR and RDRP271–276LPVGGN peptides (see Table 
3). In addition, Table 3 shows that the commonality between 
the virus polyprotein and a human antigen can also occur at the 
heptapeptide level (see myosin-IXa and dystrophin).
Table 3 shows that influenza A overlaps occur in a   number 
of human proteins that, when altered, have been reported to 
be possibly related to autism and behavioral   disorders with 
deficits in social communication and interaction. However, 
the number of antigens potentially   associated with autism and 
presenting viral motifs may be larger. Indeed,   postmortem 
studies of the brain in autism have shown a broad spectrum of 
abnormalities in the   cerebellum and neocortex,   involving lim-
bic regions, such as the anterior cingulate cortex.45   Following 
proteomic analysis of the anterior cingulate cortex in major 
  psychiatric disorders and comparing protein spots between 
control and disease groups, a number of   cytoskeletal and 
  mitochondrial proteins appeared dysregulated in psychiatric 
disorders.46 Among them, there are glutamate   dehydrogenases, 
described in Table 2.
Finally, Table 4 documents that viral hexapeptide 
sequences occur in 17 human proteins that have been related 
to myelin and (de)myelination processes.47–68 Moreover, 
many of the proteins described in Table 4 have also been 
associated with other pathologies, such as bipolar disorder, 
schizophrenia, congenital cataracts, facial dysmorphism, 
or neuropathy syndrome. On the whole, again, we observe 
that the viral-vs-human overlap is physiologically extremely 
  complex regarding the functions and the pathological involve-
ment of the human proteins involved.
Quantitative and qualitative analysis  
of the hexapeptide overlap of TMV coat 
protein vs the human proteome
Searching for controls, we also investigated the extent of pep-
tide sharing between human proteins and viruses that do not 
infect humans, such as TMV and brome mosaic virus (BMV), 
ie, 2 viruses that specifically infect plants. We found that the 
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Table 3 Hexapeptide sharing between influenza A polyprotein and human proteins potentially associated with autism, Williams–Beuren 
syndrome, Bardet–Biedl syndrome, and schizophrenia
Influenza A hexapeptide Human protein descriptiona
Protein Aa pos Sequence
nsP1 145 VSLRAF Q6ZN28: Metastasis-associated in colon cancer protein 1 (MAcc1).  Acts as a transcription activator for MeT 
and as a key regulator of hgF-MeT signaling. Alterations in MeT and hgF-MeT signaling have been associated 
with autism.20
162 PIPSVP VASH: Vasohibin-1. Angiogenesis inhibitor. Highly expressed in fetal organs. Expressed in brain and placenta. 
Associated with autism.21
neP 25 SVDLNG NRX1Ab: neurexin i-α. neuronal cell surface protein that may be involved in cell recognition and adhesion. 
Tissue specificity: heart and brain. Associated with autism.22
42 rDsLge Q9H8T5c: Myosin-iXa. Unconventional myosin-9a. regulates rho activity in neurons, and has a role in the 
regulation of neuronal morphology and function. candidate gene for the Bardet–Biedl syndrome, which may 
be characterized by retinal dystrophy, obesity, mental retardation, repetitive behavior, and some autistic-like 
features.23
43 DsLges Q9H8T5c: Myosin-iXa see previous entry.23
247 sngQAs CSMD1: cUB and sushi domain-containing protein 1. expressed at intermediate level in brain, including 
cerebellum, substantia nigra, hippocampus, and fetal brain. Disruption of the csMD1 gene is associated with 
speech delay, autism, and learning difficulties.24
hA 64 KPLiLr BBS10b: Bardet–Biedl syndrome 10 protein. Probable molecular chaperone. Defects in BBs10 are the 
cause of Bardet–Biedl syndrome type 10, characterized by severe retinopathy, early onset of obesity, 
polydactyly, hypogenitalism, renal malformation, mental retardation, repetitive behavior, and some autistic-
like features.
nc 25 IRASVG C1TC: c-1-tetrahydrofolatesynthase. includes methylenetetrahydrofolate dehydrogenase, 
methenyltetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase. Defects in this trifunctional 
enzyme may cause susceptibility to folate-sensitive neural tube defects, such as open spina bifida and anencephaly. 
Aberrations in folate metabolic pathway might have a role in the altered susceptibility to schizophrenia, autism, 
and depression.25,26
335 sAAFeD BAZ1B: Williams syndrome transcription factor. Tyrosine-protein kinase BAZ1B. involved in chromatin 
remodeling and acts as a transcription regulator. Ubiquitous. expressed at equal levels in 19–23 week-old 
fetal tissues. chromosomal aberrations involving BAZ1B may be the cause of certain cardiovascular and 
musculoskeletal abnormalities observed in Williams–Beuren syndrome.
390 Trsggn NRX1Ab: neurexin i-α. Associated with autism. see earlier entry.22 
NRX1B: neurexin-1-β. involved in cell adhesion by forming intracellular junctions through binding to neuroligins. 
May play a role in formation or maintenance of synaptic junctions. Disruption of nrX1B has been associated with 
autism spectrum disorder.27
401 AsAgQi DISC1: Disrupted in schizophrenia 1 protein. Expressed in the dentate gyrus of the hippocampus, and temporal 
and parahippocampal cortices and cells of the white matter. expression rises within the dentate gyrus and 
temporal cortex from the neonatal period to infancy, declines markedly in adolescence, and declines further with 
aging. Defects in DISC1 may be associated with (1) susceptibility to schizophrenia, and psychosis; (2) susceptibility 
to schizoaffective disorder characterized by the co-occurrence of symptoms of both mood disorder and 
psychosis; (3) autism and Asperger syndrome.28
PA 2 EDFVRQ MAGG1: Melanoma-associated antigen g1. Ubiquitous.  Associated with autism.29
131 YLeKAn DMDc: Dystrophin. May play a role in anchoring the cytoskeleton to the plasma membrane. Defects in dystrophin 
are the cause of the following: (1) Duchenne muscular dystrophy, with proximal muscle weakness causing 
waddling gait, toe-walking, lordosis, frequent falls, and difficulty in standing up and climbing up stairs (most  
patients are confined to a wheelchair by the age of 10 or 12 y; contractures and scoliosis ultimately occur); (2) 
Becker muscular dystrophy, later in onset and more benign; and (3) cardiomyopathy dilated X-linked type 3B. 
Associated with autism spectrum disorder.30,31
132 LeKAnK DMDc: Dystrophin. Associated with autism spectrum disorder. see previous entry.30,31
377 EKVDFE O75129:  Astrotactin-2.  A neuronal cell surface protein expressed on postmitotic neuronal precursors in the 
cerebellum, hippocampus, cerebrum, and olfactory bulb.  Astrotactin mediates neuronastroglial interactions and 
is also implicated in synaptic development as well as many other neuronal activities. Mutations in the astrotactin 
gene are linked to neuronal migration. Involved in autism and schizophrenia.32,33
389 DLrQYD SBP1: selenium-binding protein 1. highly expressed in liver, lung, colon, prostate, kidney, and pancreas. Present in 
neurons and glia. Upregulated in brain and blood from schizophrenia patients.34
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400 PrsLAs RELN: reelin. Plays a role in layering of neurons in the cerebral cortex and cerebellum.  Abundantly produced 
during brain ontogenesis by the Cajal–Retzius cells and other pioneer neurons located in the telencephalic 
marginal zone and by granule cells of the granular layer of the cerebellum. In adult brain, preferentially expressed 
in gABAergic interneurons of prefrontal cortices, temporal cortex, hippocampus, and glutamatergic granule cells 
of cerebellum. expression in postnatal human brain is high in the cerebellum. Defects in reLn are the cause of 
lissencephaly type 2 (norman–roberts syndrome). individuals are ataxic and mentally retarded, and suffer from 
epilepsy. Defects in RELN may contribute to susceptibility to schizophrenia. Expression of the protein is reduced 
to about 50% in patients with schizophrenia. Defects in RELN may predispose to autistic disorder.35,36
513 NDTDVV DPP10: inactive dipeptidyl peptidase 10. May modulate activity of the K+ channels KcnD1 and KcnD2. 
Defects in DPP10 may be a cause of susceptibility to asthma. Associated with autism.37
rDrP 271 LPVGGN BBS10b: Bardet–Biedl syndrome 10 protein. see earlier entry.
299 sFTiTg L1CAM: neural cell adhesion molecule L1. involved in the development of the nervous system. involved in 
neuron–neuron adhesion, neurite fasciculation, outgrowth of neurites, etc. Defects in L1cAM are the cause of 
(1) hydrocephalus due to stenosis of the aqueduct of Sylvius, with abnormal accumulation of cerebrospinal fluid 
in the brain; (2) crAsh syndrome (corpus callosum hypoplasia, psychomotor retardation,  Adducted thumbs, 
Spastic paraparesis, and Hydrocephalus), with spasticity and hyperreflexia of lower limbs, shuffling gait, mental 
retardation, aphasia, and adducted thumbs; and (3) spastic paraplegia X-linked type 1, characterized by progressive 
weakness and spasticity of the lower limbs. Associated with neurological disorders such as autism, 3p syndrome, 
and schizophrenia.38
PB2 295 VDILRQ BAZ1A: Bromodomain adjacent to zinc finger domain protein 1A. Williams syndrome transcription factor-
related chromatin-remodeling factor 180. involved in the formation or maintenance of heterochromatin playing a 
critical role in developmental control. expressed in the testis. Williams syndrome patients are diagnosed by their 
unique profile of physical and mental abnormalities. Some degree of mental retardation, visual–spatial processing 
defects, as well as characteristic “elfin” features are obvious traits of most patients.39
314 AMgLri CECR1: Adenosine deaminase cecr1. cat eye syndrome critical region protein 1. in embryo, expressed in the 
outflow tract and atrium of the developing heart, the VII/VIII cranial nerve ganglion, and the notochord. Candidate 
gene for the cat eye syndrome, a developmental disorder characterized by coloboma of the iris, anal atresia 
with fistula, downslanting palpebral fissures, heart and renal malformations, and normal or near-normal mental 
development. has been associated with autism.40
319 isssFs WBS23: Williams–Beuren syndrome chromosomal region 23 protein. 
PAX6: Paired box protein Pax-6. Oculorhombin.  Aniridia type ii protein. required for the differentiation of 
pancreatic islet α cells. Regulates specification of the ventral neuron subtypes. Present in fetal eye, brain, spinal cord, 
and olfactory epithelium. Defects in PAX6 are the cause of (1) aniridia type II, characterized by absence of the iris, 
absence of the fovea, malformations of the lens and anterior chamber; (2) Peters anomaly, consisting of a central 
corneal leukoma; (3) ectopia pupilla; (4) autosomal dominant keratitis, with corneal opacification and vascularization, 
and by foveal hypoplasia; (5) ocular coloboma (may cause as much as 10% of the childhood blindness); and (6) 
Gillespie syndrome, with aniridia cerebellum ataxia and mental deficiency. Has been associated with autism.41
346 TgnLQT Q8N2F4: cell adhesion molecule 1. cADM1. May act in synapse assembly. May be involved in neuronal 
migration, axon growth, path finding, and fasciculation on the axons of differentiating neurons. Mutations in the 
gene encoding cADM1 are associated with autism spectrum disorder.42
371 TAiLrK NBEA: Neurobeachin. Lysosomal-trafficking regulator 2. Protein BCL8B. LYST2. Expressed predominantly in the 
brain. neurobeachin has been associated with idiopathic autism and is disrupted in patients with multiple myeloma.43
388 grDeQs MYH9: Myosin-9. nonmuscle myosin heavy chain iia. Defects in MYh9 are a cause of hegglin anomaly, sebastian 
syndrome, Fechtner syndrome,   Alport syndrome, nonsyndromic sensorineural deafness, and macrothrombocy-
topenia with progressive sensorineural deafness. May be related to many neurological disorders such as depres-
sion and autism with only a subclinical platelet defect.44
aUniProt/swissprot accession numbers are given in bold. For additional references and potential disease involvement, refer to www.uniprot.org; bneurexin i-α and Bardet–
Biedl syndrome-10 protein have 2 viral hexamers; cMyosin-iXa and dystrophin have a viral heptamer.
hexapeptide extent comparable to that of the influenza A virus 
(Kanduc, unpublished data). As an illustrative example, Tables 5 
and 6 detail the quantitative and qualitative hexapeptide overlap 
of TMV coat protein vs the human proteome.
Table 5 shows that the TMV coat protein has a hexa-
peptide overlap with human proteins about 3.8-fold 
higher than the theoretical value. That is, it is even higher 
than the overlap value found with influenza A virus 
(Table 1). Moreover, the TMV coat protein-vs-human 
proteome overlap involves numerous human proteins 
specifically expressed or highly abundant in the human 
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Table 4 Influenza A hexapeptide occurrences in human proteins related to myelination
Influenza A hexapeptide Human protein descriptiona
Protein Aa pos sequence
hA 116 eLKhLL Q5VUM2: Laminin subunit α-2. Merosin heavy chain. LAMA2. involved in the attachment, migration, and 
organization of cells into tissues during embryonic development. Defects in LAMA2 are the cause of merosin-
deficient congenital muscular dystrophy type 1A, characterized by difficulty in walking, hypotonia, hyporeflexia, 
and white matter hypodensity on Mri. A single point mutation in the Ln domain of LAMA2 may cause muscular 
dystrophy and peripheral amyelination.47
442 AELLVL NFL: Neurofilament light polypeptide. NEFL. Involved in the maintenance of neuronal caliber. Defects in NEFL 
are the cause of CMT disease type 1F (CMT1F), characterized by severely reduced nerve conduction velocities 
(less than 38 m/s), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly 
progressive distal muscle atrophy and weakness, absence of deep tendon reflexes, and hollow feet. The CMT1F 
condition is characterized by onset in infancy or childhood (range 1–13 yr). Defects in NEFL are the cause of 
CMT disease type 2E, characterized by signs of axonal regeneration in the absence of obvious myelin alterations 
and progressive distal muscle weakness and atrophy.48
nA 26 igniis CH60: 60 kDa heat shock protein, mitochondrial. hsP-60. cPn60. Mitochondrial matrix protein P1. hsPD1. 
Defects in HSPD1 are a cause of (1) spastic paraplegia, a degenerative spinal cord disorder characterized by a 
progressive weakness and spasticity of the lower limbs and (2) leukodystrophy hypomyelinating type 4, a severe 
hypomyelinating leukodystrophy, characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, 
neurologic regression, and mental retardation.49,50
107 rigsKg MYEF2: Myelin expression factor 2. Transcriptional repressor of the myelin basic protein gene.
201 GAVAVL Q4KMR1: synaptojanin-1. synaptic inositol-1,4,5-trisphosphate 5-phosphatase 1. isoform 1 is more enriched 
than isoform 2 in developing brain. isoform 2 is abundant in nerve terminals. Possibly involved in the development 
of chromosome 21q22-linked bipolar disorders and schizophrenia. May contribute to brain dysfunction and 
cognitive disabilities in Down’s syndrome. involved in the interaction of myelin basic protein with the plasma 
membrane in oligodendroglial cells.51–53
202 AVAVLK ARHGA: rho guanine nucleotide exchange factor 10. ArhgeF10. Defects in ArhgeF10 cause slow nerve 
conduction, without any clinical signs of peripheral or cns dysfunction. involved in developmental myelination of 
peripheral nerves.54
nP 178 AAGAAV CTDP1: rnA polymerase ii subunit A c-terminal domain phosphatase. TFiiF-associating cTD phosphatase. 
Processively dephosphorylates “Ser-2” and “Ser-5” of the heptad repeats YSPTSPS in the COOH domain of the 
largest rnA polymerase ii subunit. This promotes the activity of rnA polymerase ii. The phosphorylation is required 
for the physical interaction with gTF2F1. Defects in cTDP1 may cause congenital cataracts facial dysmorphism 
neuropathy syndrome, with hypogonadism, hypomyelination of the peripheral nervous system, and delayed motor 
and intellectual development. central nervous system involvement, with cerebral and spinal cord atrophy, may be the 
result of disrupted development. Affected individuals are prone to severe rhabdomyolysis after viral infections and to 
serious complications related to general anesthesia as pulmonary edema and epileptic seizures.55
282 GLAVAS ATRN: Attractin. Mahogany homolog. Involved in the initial immune cell clustering during inflammatory 
response. involved in melanocortin signaling pathways that regulate energy homeostasis and hair color. has a 
critical role in normal myelination in the cns.56,57
283 LAVASG SOX10: Transcription factor SOX-10. Could confer cell specificity to the function of other transcription 
factors in developing and mature glia. expressed in fetal brain and in adult brain, heart, small intestine, and colon. 
Defects in sOX10 are the cause of (1) Waardenburg syndrome type 2e, with sensorineural deafness, pigmentary 
disturbances, and absence of dystopia canthorum; (2) Waardenburg syndrome type 4, with association of 
Waardenburg features (depigmentation and deafness) and the absence of enteric ganglia in the distal part of 
the intestine (hirschsprung disease); (3) Yemenite deaf–blind hypopigmentation syndrome, with cutaneous 
hypopigmented or hyperpigmented spots and patches, microcornea, coloboma, and severe hearing loss; and 
(4) PcWh, with features of Peripheral   demyelinating neuropathy, central dysmyelinating leukodystrophy, 
Waardenburg syndrome, and hirschsprung disease.58,59
372 eTMDss Q16301: replication initiation-like protein. Myelin transcription factor 2. MyT2. cerebrin-50. Binds to 
the promoter of the myelin proteolipid protein. Strongly detected in cerebrospinal fluid. Expressed in 
oligodendrocyte progenitor cells, pyramidal and Purkinje neurons, neurons of the hypothalamus, hippocampus, 
ventromedial thalamus, cells of the choroid plexus, and ciliated ependymal cells.60
389 rTrsgg Q9P0W5: schwannomin-interacting protein 1. schiP-1. component of both axon initial segments and nodes 
of ranvier, essential regions for saltatory conduction of the action potential along the axon, in the central and 
peripheral nervous systems. isoforms 5 and 6 are highly expressed in the brain.61
rDrP 363 KLrTQi MYT1L: Myelin transcription factor 1-like protein. MyT1L protein. May function as a panneural transcription 
factor associated with neuronal differentiation with a role in the development of neurons and oligodendrogalia in 
the CNS. Involved in schizophrenia.33
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Table 4 (Continued)
Influenza A hexapeptide Human protein descriptiona
Protein Aa pos Sequence
513 GVSGIN PRAX: Periaxin. PrX. involved in the early phases of myelin deposition, in the maintenance of peripheral nerve 
myelin sheath, and in axon–glial interactions, by interacting with the cytoplasmic domains of integral membrane 
proteins such as myelin-associated glycoprotein in the periaxonal regions of the schwann cell plasma membrane. 
isoforms 1 and 2 are found in sciatic nerve and schwann cells. Defects in PrX are a cause of Dejerine–sottas 
syndrome, a neuropathy of the demyelinating CMT disease category, with onset by age 2 yr, characterized by 
motor and sensory neuropathy with slow nerve conduction velocities, increased cerebrospinal fluid protein 
concentrations, hypertrophic nerve changes, and delayed age of walking as well as areflexia.62,63
PB2 113 KVYKTY TSN3: Tetraspanin-3. Tspan-3. regulates the proliferation and migration of oligodendrocytes, a process essential 
for normal myelination and repair.64
185 iTKeKK MTMRD: Myotubularin-related protein 13. sBF2. expressed in spinal cord. Defects in sBF2 are the cause of 
cMT4B2, a recessive form of cMT disease, the most common inherited disorder of the peripheral nervous 
system, characterized by abnormal folding of myelin sheaths with pathological hallmarks on nerve biopsies 
including concentric sheaths (onion bulbs).65,66
190 KeeLQD SYYC: Tyrosyl-trnA synthetase, cytoplasmic. Tyrrs. YArs. Defects in YArs are the cause of cMT disease 
dominant intermediate type C, a form of CMT disease characterized by clinical and pathologic features 
intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction 
velocities ranging from 25 to 45 m/s.67
746 DsQTAT IKAP: iκB kinase complex-associated protein. iKBKAP. May play a role in chromatin remodeling and is involved 
in acetylation of histones h3 and probably h4. Defects in iKBKAP are the cause of familial dysautonomia or 
riley–Day syndrome or hereditary sensory and autonomic neuropathy type iii due to progressive degeneration 
of the sensory, sympathetic and parasympathetic neurons. FD individuals are affected with a variety of symptoms 
such as decreased sensitivity to pain and temperature, cardiovascular instability, recurrent pneumonias, vomiting 
crises, and gastrointestinal dysfunction. IKAP/hELP1 deficiency in the cerebrum of familial dysautonomia patients 
results in down regulation of genes involved in oligodendrocyte differentiation and in myelination.68
aUniProt/swissprot accession numbers are given in bold. For additional references and potential disease involvement, refer to www.uniprot.org
Discussion
The present study shows that a high number of influenza 
A H5N1 hexapeptides are seen in numerous human proteins 
that play a crucial role in neural networks and functions. 
This finding might help one to understand the neuropatho-
genesis of influenza-associated encephalopathy that still 
remains unclear.69,70 In this regard, a recent report has 
described significant expression changes in cytoskeleton 
proteins,   proteins associated with the ubiquitin–proteasome 
pathway, and   neural signal transduction proteins in chicken 
brain   following influenza H5N1 infection.71 Interestingly, 
many proteins, the expression of which changed in the 
H5N1-infected brain (ie, tubulin, phosphoglucomutase-1, 
ubiquitin carboxyl-terminal hydrolase 3, vimentin, 26S 
proteasome subunit S5B, tyrosine 3-monooxygenase/ 
tryptophan 5-monooxygenase activation protein, β polypep-
tide, septin, and tubulin-specific   chaperone D), are listed in 
Table 2 as proteins that share hexapeptide motifs with the 
viral H5N1 polyprotein. From this point of view, the present 
report offers a molecular basis to investigate the possible 
link(s) between influenza viruses and neuropathogenesis, 
especially considering that short peptides are functional 
modules playing a central role in enzyme activity, cell–cell 
adhesion, hormone activity, and regulation of oncoprotein 
expression.8,72,73
The remarkable viral-vs-human peptide commonality is not 
exclusive of the influenza A H5N1 virus, but this   phenomenon 
has been found in a number of different viruses, with differ-
ent tissue tropism and pathogenicity.5 In addition, as a datum 
of relevant interest, for the first time this study demonstrates 
that there is a high level of peptide sharing between the human 
proteome and the coat protein from TMV , a virus that does not 
infect humans. Even more surprisingly, many of the TMV coat 
protein hexapeptides occur in human-brain-specific proteins. 
From an evolutionary point of view, these findings raise the 
fundamental question of what are the phenetic links between 
viruses and Homo sapiens. Indeed, Tables 5 and 6 seem to indi-
cate that the phenetic similarities at the protein level between 
humans and viruses do not derive from a convergent evolution 
process catalyzed by a selective pressure. Or, in other words, 
the phenetic amino acid sequence identity (ie, the peptide   
Table  5  Description  in  numbers  of  the  hexapeptide  overlap 
between TMV coat protein and the human proteome
Unique viral hexamers 154
Viral hexamers occurring in the human proteins 75
expected number of viral hexamer occurrences 
in the human proteome
19.84Biologics: Targets & Therapy 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
257
Hexapeptide sharing: influenza virus vs Homo sapiens
Table 6 Human proteins sharing hexapeptide sequence(s) with TMV coat protein
Sequence Matches Human protein(s) descriptiona
TTPsQF 2 BIN1: Myc box-dependent-interacting protein 1.  
NIPBL: nipped-B-like protein.
VFLSSA 2 FRAS1: extracellular matrix protein FrAs1. highest levels found in kidneys, pancreas, and thalamus.  
R3HC1: r3h and coiled-coil domain-containing protein 1.
LssAWA 1 SC6A3: Sodium-dependent dopamine transporter. Terminates the action of dopamine by its high affinity sodium-
dependent reuptake into presynaptic terminals.
sAWADP 1 NACAD: nAc-alpha domain-containing protein 1.
WADPie 1 HNRPQ: heterogeneous nuclear ribonucleoprotein Q. Detected in the heart, brain, pancreas, and placenta.
LinLcT 1 GP112: Probable g-protein coupled receptor 112. Detected in fetal retina. highly expressed in normal 
enterochromaffin cells and in neuroendocrine carcinoma.
cTnALg 1 EMR1b: egF-like module-containing mucin-like hormone receptor-like 1.
nALgnQ 1 TACC2: Transforming acidic coiled-coil-containing protein 2. Acts in the nuclear migration of neural 
progenitors.
FQTQQA 2 TM40L: Mitochondrial import receptor subunit TOM40B.  
ZN687: Zinc finger protein 687.
QARTVV 1 FND3A: Fibronectin type-iii domain-containing protein 3A expressed in odontoblasts.
TVVQRQ 1 RBM22: Pre-mrnA-splicing factor rBM22.
RQFSEV 1 Q96CH6: Mgc20647 protein.
PSPQVT 1 NBAS: Neuroblastoma-amplified gene protein.
SPQVTR 2 NPHP1: Juvenile nephronophthisis 1 protein.  
VRK3: Serine/threonine-protein kinase VRK3.
PQVTRF 1 Q6ZR66: The cDNA FLJ46600 fis, clone THYMU3047144.
TVRFPD 1 ACHA7: neuronal acetylcholine receptor subunit α-7.
DSDFKV 1 PHF14: Putative uncharacterized protein PHF14.
FKVYRY 1 TRIM2: Tripartite motif-containing protein 2.
YNAVLD 1 QSOX2: neuroblastoma-derived sulfhydryl oxidase 2. expressed in pancreas, brain, placenta, and fetal tissues.
VLDPLV 1 LPAR5: Lysophosphatidic acid receptor 5.
LDPLVT 2 LZTS1: Leucine zipper putative tumor suppressor 1. Involved in the regulation of cell growth. Highly expressed in   
testis, prostate, spleen, thymus, ovary, and brain.  
Q08E86: KiAA0100 protein.
LVTALL 2 KLRAQ: KLrAQ motif-containing protein 1.  
TENS4: c-terminal tensin-like protein.
VTALLG 3 KDM5C: Lysine-specific demethylase 5C. Defects in KDM5C are the cause of mental retardation. syndromic 
X-linked JAriD1c-related.  
O52B4: Olfactory receptor, family 52, subfamily B, member 4.  
MSLNL: Mesothelin-like protein.
TALLgA 1 STRA6: stimulated by retinoic acid gene 6 protein homolog.
ALLgAF 1 TRUA: The trnA pseudouridine synthase A.
Trnrii 1 A6NIH1: Putative uncharacterized protein ENSP00000350479.
NRIIEV 1 TIF1A: Transcription intermediary factor 1-alpha.
RIIEVE 1 B7Z872:  cDnA FLJ56895, highly similar to echinoderm microtubule-associated protein-like.
IIEVEN 3 SEP12: septin-12. Widely expressed.  
CC110: coiled-coil domain-containing protein 110.  
SEPT3: Neuronal-specific septin-3. Upregulated during neuronal differentiation.
EVENQA 2 COG5: conserved oligomeric golgi complex subunit 5.
PTTAeT 1 SFRS8: sFrs8 protein.
TTAeTL 2 REEP2: receptor expression-enhancing protein 2. Detected in the brain, heart, and skeletal muscle.  
BPIc: Bactericidal permeability-increasing protein.
TAeTLD 2 KLD8B: Kelch domain-containing protein 8B.  
BPIc: Bactericidal permeability-increasing protein.
eTLDAT 1 SYFA: Phenylalanyl-trnA synthetase α chain.
DDATVA 1 FBXW8: F-box/WD repeat-containing protein 8.
DATVAI 1 S13A5: solute carrier family 13 member 5.
AirsAi 1 B4DVQ1: The cDnA FLJ59288. highly similar to roundabout homolog 2.
irsAin 1 RAD17: cell cycle checkpoint protein rAD17.
NNLIVE 1 D3DXA2: Brain expressed X-linked 2 protein, isoform crA_a.
NLIVEL 1 CS051: UPF0470 protein c19orf51.
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Table 6 (Continued)
Sequence Matches Human protein(s) descriptiona
LirgTg 1 SRPRc: signal recognition particle receptor subunit α.
irgTgs 2 SRPRc: signal recognition particle receptor subunit α.  
PSTK: Putative uncharacterized protein.
rssFes 2 PRUN2: BniP2 motif-containing molecule at the c-terminal region 1.  
Q5JUB6: Prune homolog 2.
ssFess 4 ARMC2: Armadillo repeat-containing protein 2.  
ANKS6: Ankyrin repeat and sAM domain-containing protein 6. required for renal function.  
ZEP3: Transcription factor HIVEP3.  
CA031: Uncharacterized protein C1orf31.
Fesssg 2 PTN13c: Protein–tyrosine phosphatase 1e. Most abundant in the lung, kidney, and fetal brain.  
EMR1b: egF-like module-containing mucin-like hormone receptor-like 1.
esssgL 4 PTN13c: Protein–tyrosine phosphatase 1e. Most abundant in the lung, kidney and fetal brain.  
NF2L1: nuclear factor erythroid 2-related factor 1.  
RGS9: regulator of g-protein signaling 9. highly expressed in the caudate and putamen.  
Q9Y628: Putative uncharacterized protein.
SGLVWT 1 AL8A1: Aldehyde dehydrogenase family 8 member A1.
LVWTSG 1 EIF3L: eukaryotic translation initiation factor 3 subunit L.
TsgPAT 5 MUC16: Ovarian carcinoma antigen cA125.  
K1755: Uncharacterized protein KIAA1755.  
SF01: splicing factor 1.  
MAP2: Microtubule-associated protein 2.  
A2RRB4: regulation of transcription, DnA dependent.
aUniProt/Swissprot accession numbers are given in bold. Brain and/or peripheral nervous system localization given in boldface. For references and potential disease involvement, 
visit www.uniprot.org; bThe eMr1, egF-like module-containing mucin-like hormone receptor-like 1 contains 2 viral hexapeptides; cThe bactericidal permeability-increasing 
protein (BPi); signal recognition particle receptor (srPr) subunit α; and protein-tyrosine phosphatase 1e (PTn13) have 2 consecutive overlapping viral hexamers.
sharing between viruses and humans) appears to occur 
independently of the host’s susceptibility to a viral infection. 
In this frame, the remarkable viral-vs-human peptide com-
monality suggests that one should rethink and redefine the 
evolutionary links between entities that are phylogenetically 
different such as viruses and Homo sapiens.
In addition, the viral-vs-human peptide sharing may 
also offer an interpretation key for the enigmatic ability 
of   influenza viruses to escape from humoral and cellular 
immune recognition.74,75 Antigenic drift (ie,   accumulation 
of mutations in influenza surface glycoproteins, HA, 
and NA, and/or in cytotoxic T-lymphocyte epitopes) and 
antigenic shift (ie, introduction of new viral subtypes) 
have been proposed as the main mechanisms allowing 
escape from host immune surveillance.76 In addition, the 
peptide identity platform existing between the influenza 
A polyprotein and human proteome may be a concomitant 
factor in successful influenza pandemics. As a matter of 
fact, a human anti-influenza immune reaction might be 
prevented a priori by powerful self-tolerance mechanisms 
fully operating in our body. According to Ehrlich, the 
immune system is prevented from mounting an attack 
against self-antigens, thereby avoiding the harmful 
autodestruction of the tissues it was designed to protect: 
“It would be exceedingly dysteleologic if in this situation 
autotoxins were formed”. Ehrlich named this concept 
“horror autotoxicus”.77
Hence, as already suggested,78,79 it is possible that 
the massive peptide overlap existing between microbes 
and the human host is the main obstacle to an immune 
  reaction against   infectious agents, thus explaining the 
scarce   immunogenicity of influenza viruses in humans.74,75 
Accordingly, in   vaccination procedures and protocols, 
the simple administration of an influenza virus gener-
ally does not elicit a powerful immune response. To 
increase immunogenicity, often anti-influenza vaccines 
contain adjuvants,80 ie, compounds that appear to act by 
increasing antigen availability and uptake by immune 
cells, activating innate immunity pathways in vivo, and 
generating an immunocompetent environment at the 
injection site.81 Through these multiple and not yet fully 
understood mechanisms, adjuvants bypass the host immu-
notolerance mechanisms and determine powerful immune 
responses. This means as a logical consequence of the 
peptide commonality between the virus and the human 
host, the adjuvant-  potentiated anti-influenza reaction Biologics: Targets & Therapy 2010:4 submit your manuscript | www.dovepress.com
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may enhance cross-reactivity with sequences shared with 
human proteins (Tables 2–4). In this context, it is worth 
recalling that 5–6 amino acids can form a sufficient mini-
mal determinant for an epitope–paratope interaction, so 
that the hexapeptides described in Tables 2–4 may act as 
immune units and play a role in cell immunoreactivity and 
antigen–antibody recognition.8,9
In conclusion, the findings presented here may be of help 
not only for a more thorough analysis of the relationship(s) 
between influenza viruses and humans but also for   designing 
safe peptide-based anti-influenza vaccines.82 Indeed, 
  selecting unique viral sequences and, conversely, discarding 
viral sequences shared with human proteins may eliminate 
side effects due to cross-reactivity.15,83–85
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